|
Real-time Estimate
Cboe BZX
03:08:03 19/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 2.820 USD | -1.05% |
|
-18.89% | -45.25% |
| 06/11 | SCYNEXIS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 23/10 | SCYNEXIS, Inc. Completes Phase 1 Study Of Intravenous SCY-247 | CI |
Company Valuation: SCYNEXIS, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 174 | 50.94 | 82.97 | 45.92 | 26.54 | 28.37 | - | - |
| Change | - | -70.72% | 62.87% | -44.66% | -42.2% | 6.89% | - | - |
| Enterprise Value (EV) | 174 | 50.94 | 82.97 | 45.92 | 26.54 | 28.37 | 28.37 | 28.37 |
| Change | - | -70.72% | 62.87% | -44.66% | -42.2% | 6.89% | 0% | 0% |
| P/E | -4.88x | -1.06x | 1.6x | -2.75x | -3.72x | -0.91x | -1.46x | -1.65x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0.1x | -0x | 0x | 0.1x | -0x | 0x | 0.1x |
| Capitalization / Revenue | 13.2x | 10x | 0.59x | 12.3x | 1.29x | 72.1x | 2.93x | 2.01x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 72.1x | 2.93x | 2.01x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | 0x | -0x | -0x | -0.67x | -1.08x | -1.18x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -10 | -11.76 | 11.12 | -3.52 | -1.36 | -3.13 | -1.953 | -1.73 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 13.16 | 5.091 | 140.1 | 3.746 | 20.6 | 0.3933 | 9.687 | 14.08 |
| EBITDA | - | -85.15 | - | - | - | - | - | - |
| EBIT 1 | -60.84 | -85.76 | 72.67 | -37.12 | -16.07 | -42.61 | -26.35 | -23.95 |
| Net income 1 | -32.87 | -62.81 | 67.04 | -21.29 | -8.609 | -32.83 | -24.63 | -23.6 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 48.800 | 12.480 | 17.840 | 9.680 | 5.059 | 2.850 | 2.850 | 2.850 |
| Nbr of stocks (in thousands) | 3,565 | 4,082 | 4,651 | 4,744 | 5,246 | 9,953 | - | - |
| Announcement Date | 29/3/22 | 31/3/23 | 28/3/24 | 12/3/25 | 4/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.91x | - | - | - | 28.37M | ||
| 41.43x | 14.03x | 29.73x | 0.48% | 1,261B | ||
| 40.79x | 6.85x | 19.26x | 1.91% | 671B | ||
| 37.33x | 8.57x | 17.72x | 2.36% | 518B | ||
| 21.83x | 5.29x | 13.24x | 2.47% | 387B | ||
| 101.76x | 5.82x | 24.8x | 2.37% | 353B | ||
| 23.99x | 5.78x | 14.05x | 2.75% | 300B | ||
| 23.93x | 4.79x | 13.46x | 1.83% | 283B | ||
| 23.64x | 7.27x | 13.36x | 2.2% | 248B | ||
| -40.04x | 7.4x | 46.61x | 1.94% | 211B | ||
| Average | 27.38x | 7.31x | 21.36x | 2.03% | 423B | |
| Weighted average by Cap. | 36.56x | 8.81x | 22.37x | 1.7% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SCYX Stock
- Valuation SCYNEXIS, Inc.
Select your edition
All financial news and data tailored to specific country editions
















